International Aspirin Foundation publishes a report on the work of highly commended investigators

The International Aspirin Foundation has published a report of the Winner and Highly Commended awardees, present at the prestigious Emerging Aspirin Investigator Award Ceremony.

Featuring research into aspirin and chemoprevention, pre-eclampsia and frailty prevention as well optimizing dosing levels, the report highlights the variety of work currently being led by early career researchers into the different medical uses and impacts of the drug.

The report leads with Emerging Aspirin Investigator Award 2021 Winner Dr Tracey Simon MD MPH, Hepatologist, Division of Gastroenterology, Instructor of Medicine, Harvard Medical School, USA and her work on Aspirin and Primary Prevention of Hepatocellular Carcinoma.

It also features the Highly Commended candidates: Dr Helga Helgadóttir, Associate Professor, Faculty of Pharmaceutical Sciences, University of Iceland and her work on the prophylactic use of aspirin to prevent the development of pre-eclampsia in pregnancy;

Dr Holli Loomans-Kropp, Postdoctoral Fellow, GIORG National Cancer Institute (NCI), USA and her work on the association between aspirin use and cancer risk in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial;

Dr Ariela Orkaby, MD MPH Geriatrics and Preventative Cardiology, Assistant Professor of Medicine, Harvard Medical School, Brigham and Women's Hospital, VA Boston Healthcare System GRECC, USA and her work on the association between aspirin use and a decreased risk of frailty and functional limitation in older men;

Dr William Parker, MA MB BChir PhD SRPharmsS MRCS MRCP, British Heart Foundation Clinical Research Training Fellow in Cardiology, University of Sheffield and Registrar in Cardiology at Sheffield Teaching Hospitals NHS Foundation Trust, UK and his work on optimising aspirin dosing for patients with high-risk coronary syndromes: the WILLOW programme.

Dr Lucia Cea Soriano PharmD PhD, Assistant Professor at the Department of Preventive Medicine and Public Health, Faculty of Medicine, Complutense University of Madrid, Madrid, Spain, who was unable to attend the meeting, was also recognized and awarded a certificate of commendation.